The Business Times

Pharmaceuticals

Companies & Markets

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

Novo Nordisk has gone from being Europe’s most valuable listed company to losing more than US$300 billion in market value.
Opinion & Features
THINKING ALOUD

How I knew when to start backing Novo Nordisk’s biggest rival instead

iX Biopharma had intended to raise at least S$5 million from the exercise, with new shares issued at S$0.10 apiece. 
Companies & Markets

iX Biopharma raises gross proceeds of S$6.7 million from placement

Logos sit above windows at Novartis AG's headquarters in Basel, Switzerland, on Tuesday, July, 16, 2013. Novartis raised its profit and sales forecasts as generic competition for the Diovan blood-pressure medicine failed to materialize in the U.S. Photographer: Gianluca Colla/Bloomberg
Companies & Markets

Novartis Q3 operating income up 6% on new drug sales

iX Biopharma has proposed a placement of new shares in the company at S$0.10 apiece.
Companies & Markets

iX Biopharma proposes placement to raise gross proceeds of at least S$5 million as it eyes US expansion

A strategic tie-up with a US company could lead to the monetisation of 22 drugs under development by September 2026, iX Biopharma said.
Companies & Markets

iX Biopharma shares jump 35% on potential US, Australia listing plans

A new analysis shows that China is the sole supplier of key chemicals in widely used pharmaceutical products.
Opinion & Features

China is well positioned for a trade showdown with Trump

Sresan Pharma owner, S. Ranganathan, is escorted by Police to a local court after one of their medicines, Coldrif cough syrup, was linked to the death of multiple children in Parasia, Madhya Pradesh.
International

WHO warns against three India-made cough syrups after child deaths

Singapore mainly exports active pharmaceutical ingredients to the US, instead of finished products like tablets and capsules. Between 2022 and 2024, Singapore’s pharmaceutical exports to the US averaged S$3.7 billion per year.
Singapore

Singapore-based pharma companies waiting for confirmation of US tariff exemptions: MTI

The company currently operates a commercial site at Gurugram near India’s capital, New Delhi, and has specialised operations at Bengaluru and Hyderabad.
Consumer & Healthcare

Eli Lilly to invest US$1 billion in India contract manufacturing

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More